Bicara Therapeutics Inc : Morgan Stanley Raises Target Price to $36 From $35
Bicara Therapeutics Inc:摩根士丹利將目標價從$35上調至$36
Bicara Therapeutics Inc : Morgan Stanley Raises Target Price to $36 From $35
Bicara Therapeutics Inc:摩根士丹利將目標價從$35上調至$36
譯文內容由第三人軟體翻譯。